Study shows Kentucky endometrial cancer patients have higher rates of DACH1 mutation
Doctor who was suspended for dishonesty can practise again with conditions
12 January 2021Higher live birth rates found after transferring fresh rather than frozen embryos
12 January 2021Study shows Kentucky endometrial cancer patients have higher rates of DACH1 mutation
A new study by University of Kentucky Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.
